OSKA 0.002    Updated: 05-06-2017 $OSKA Last Trade:

Unraveling the Cybersecurity Frontier in Space These days, keeping our tech safe isn't just about stopping your phone from getting hacked or your laptop from being bombarded with spam. We're talking bigger, and I mean cosmos-level bigger. The space cybersecurity scene is ramping up, projected to balloon from $5.52 billion in 2026 to a whopping $8.59 billion by 2031....

Gildan's Channel Stuffing Allegations If July showers bring August flowers, then what do June allegations bring? A stock nosedive, if you’re Gildan Activewear. Investors woke up June 16, 2026, to a harrowing drop, with shares slipping nearly 19%. It's the kind of gut-punch that makes one wonder if summer vacation is over before it even starts. Jehoshaphat Research...

Setting the Jet Set Stage Aflame In the ever-glam world of high-end travel, TLC Jet, out of Fort Lauderdale, has just inked a deal with WIMCO St. Barth Properties. Look, if you've got a penchant for island hopping or sipping your cocktail with sand between your toes, this aligns perfectly with your luxury cravings. This duo isn't just whispering sweet nothings in the...

Health Screenings: A Step Before the Hospital Sometimes it's the basics, like a plain old health screening, that can shift the tides from crisis to care. That's exactly where AZ Blue Health Choice and Zeihan ProHealth come into the picture, aiming to pin those health concerns before they spiral out of control. For your average Arizonan who finds healthcare as elusive as a...

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Storm Clouds Over Anavex: What Investors Need to Know If you've got a slice of Anavex Life Sciences Corp. (NASDAQ: AVXL) in your portfolio, the latest chapter of their legal saga feels less like a twist and more like a twist of the knife. These lawsuits often come out of left field for investors, but this one seems like a slow train that’s been gathering steam for a...

Aruba's Fashion Pulse Returns Stronger Than Ever The 10th anniversary of Aruba Fashion Week is setting up to be a whirlwind of style and creativity, and all eyes are on Tierra del Sol by Iberostar to host this year's blockbuster event. The 'Winds of Fashion' theme celebrates both the island's dynamic landscape and the finesse of international design. Excitement is brewing...

New Season, New Style: Align™ Hits the Mark Align™ is rolling out its Fall-Winter 2026 men's footwear lineup, and if you're looking for styles that marry form with function, you're in for a treat. Launched just a year ago under the umbrella of H.H. Brown, Align's guns are blazing with a collection set to make some noise in the footwear world. Stepping Into Fall: Fresh...

Securitas AB, the grandmaster of security solutions, reported a mixed bag of results for the third quarter of 2026. With total sales clocking in at MSEK 38,566, barely nudging past the same period last year, the landscape feels both challenging and ripe with potential. The devil's in the details here, with organic sales growth flatlining at zero percent, yet real sales...

dMY IV Settlement: What You Need to Know Listen up, folks! If you've got a stake in dMY Technology Group, Inc. IV, there's big news brewing. We're talking class action, settlement talks, and a cool $11 million on the line. Let's crack open what this means for you as a holder of dMY IV Class A common stock during December 2021's whirlwind. Who Can Get a Piece of the...

Rubico Inc. Expands Financial Outlook with Charter Extensions Rubico Inc. has made headlines recently as it announces the extension of time charters for both of its modern tanker vessels, supporting its steady growth in the shipping industry. Known for its eco-friendly, fuel-efficient tanker vessels, this move reflects the company's commitment to optimizing its...

Investing in Dividend-Yielding Stocks During turbulent times in the financial markets, investors often seek refuge in dividend-yielding stocks. These stocks are typically from companies with strong free cash flows that reward their shareholders. In particular, high-yield dividend stocks can be an attractive option for those looking to generate income from their...

Foventa's Shift: From Science to Clinical Focus Well, isn't this a twist of fate? Exonate, the company that once thrived on cutting-edge science, is shedding its old skin and stepping into a new spotlight as Foventa Therapeutics. The old moniker is in the rearview, and now they're pledging to tackle non-proliferative diabetic retinopathy (NPDR) with a fresh angle—a...

Innovative Partnership Between Viz.ai and Illuminate In a significant stride for patient care, Viz.ai has announced a collaborative expansion with Illuminate, a company renowned for its advancements in AI and natural language processing. This partnership aims to revolutionize the identification and monitoring of patients with cerebral aneurysms, facilitating timely...

Trilogy Metals Shares Fiscal Insights and Project Developments Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ), a notable player in metal exploration, recently announced its financial results for the third quarter ending August 31, 2025. The latest updates detail the company's fiscal health, progressive projects, and future outlook, revealing a net loss of $1.7...